Development and dosimetry of 203Pb/212Pb-labelled PSMA ligands: bringing "the lead" into PSMA-targeted alpha therapy?
Purpose: The aims of this study were to develop a prostate-specific membrane antigen (PSMA) ligand for labelling with different radioisotopes of lead and to obtain an approximation of the dosimetry of a simulated 212Pb-based alpha therapy using its 203Pb imaging analogue. Methods: Four novel Glu-ure...
| Publicado en: | European Journal of Nuclear Medicine & Molecular Imaging Vol. 46; no. 5; pp. 1081 - 1092 |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
May2019
|
| Acceso en línea: | Ver este registro en EBSCOhost |